PRESCRIBING · PART D · 2024
Total Rx claims
753
Beneficiaries
—
Total drug cost
$9.7M
Distinct drugs
9
Brand share
97.2%
Top prescribed drugs
Acalabrutinib Maleate285 claims
Zanubrutinib196 claims
Ibrutinib119 claims
Venetoclax56 claims
Eltrombopag Olamine28 claims
CROSS-REFERENCE